Increasing challenges arising in management and generation of IT-based data in the lifesciences sector has driven the demand for effective storage solutions. As data generation rate continues to outpace vigorously, effective lifesciences enterprise storage solutions are being adopted to manage and store the clinical data such as genomics, pharmaceutical development, and drug discovery. However, high value nature of the data has lowered the adoption of lifesciences enterprise storages and leading genomics firms are becoming skeptical towards adopting storage models with potential vulnerabilities.
Pharmaceutical Companies to Represent Key Customer Segment
In 2017, nearly US$ 750 Mn worth of lifesciences enterprise storage solutions were adopted for storing data of pharmaceutical companies. The report observes that growing interconnectedness between lifescience business and pharmaceuticals industry will propel the contribution of pharmaceuticals as key customer segment in the expansion of the global lifesciences enterprise storage market. The report further reveals that biotech companies and governments will also be observed as lucrative customer segments for the global adoption of lifesciences enterprise storage solutions.
For more key insights on this market, request a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=484
Adoption of Storage Attached Networks to Gain Traction
The report estimates that by the end of 2026, more than US$ 1.1 Bn worth of lifesciences enterprise storage solutions adopted across the globe will be developed with storage-attached-network model. The demand for such storages is expected to gain traction owing to the growing integration of large data networks in lifescience entrepreneurial projects. The report further reveals that server attached storages will register fastest revenue growth, reflecting a 5.4% CAGR in terms of value over the forecast period.
On-Cloud Deployment of Lifesciences Enterprise Storages to witness an Upsurge
Currently, majority of lifesciences enterprise storages are deployed with on-premise model. Complex working of cloud-based lifesciences enterprise storage deployment will continue to factor the high revenue growth of on-premise deployment. By the end of 2026, more than US$ 1.6 Bn worth of lifesciences enterprise storages will deployed with on-premise model across the globe. The report further estimates that on-cloud deployment of lifesciences enterprise storages will register steady revenue growth at more than 5% CAGR in terms of value over the forecast period.
Inquire for the Discount on the Report: https://www.factmr.com/connectus/sample?flag=D&rep_id=484